JAGUAR HEALTH, INC. Temporary Equity, Liquidation Preference
JAGUAR HEALTH, INC. (JAGX) had Temporary Equity, Liquidation Preference of $0 as of 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Balance Sheet › Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2017-08-09
- 2015-12-31: Temporary Equity, Liquidation Preference $0.00.
- 2015-09-30: Temporary Equity, Liquidation Preference $0.00.
- 2015-06-30: Temporary Equity, Liquidation Preference $0.00.
- 2014-12-31: Temporary Equity, Liquidation Preference $6.78M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-03-29 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-13 |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-13 |
| 2014-12-31 | $6.78M 10-K · filed 2016-03-29 |
| 2014-05-31 | $6.78M 10-Q · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |